Keyphrases
Drug Resistance
73%
NSD2
61%
Pediatric Acute Lymphoblastic Leukemia
61%
Gene Expression
49%
Chick
46%
Cancer Variants
42%
Thiopurines
41%
Variant Interpretation
38%
Germ Cells
38%
Acute Lymphoblastic Leukemia
38%
Clonal Evolution
38%
Cell Context
35%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
35%
Pediatric
34%
Newly Hatched chicks
30%
Delayed Feeding
30%
Emerging Clone
30%
NTRK Fusion
30%
Transcriptional Analysis
30%
Haploinsufficiency
30%
Kinase Cascade
30%
Pituitary
30%
Favorable Histology
30%
Clinical Significance
30%
MSH6
30%
Von Hippel-Lindau Disease
30%
Peripheral Blood
30%
Hypothalamus
30%
Wilms Tumor
30%
3D Chromatin Organization
30%
Evidence-based Approach
30%
Pharmacogenetics
30%
Gene Network
30%
Machine Learning
30%
Mitogen-activated Protein
30%
Mean Fluorescence Intensity
30%
B-lymphoblastic Leukemia
30%
Von Hippel-Lindau
30%
Nucleoside Analogues
30%
Path Analysis
30%
Ontogenic
30%
Genotype-phenotype
30%
Metabolism
20%
In Cancer
20%
Knockdown
20%
Pituitary Hormones
18%
Missense
18%
MAPK Activation
18%
Somatic Variants
16%
Microarray Analysis
15%
Biochemistry, Genetics and Molecular Biology
Drug Resistance
100%
Mercaptopurine
76%
Germ Cell
71%
Germline
71%
Kinase
41%
Phosphotransferase
41%
Drug Response
38%
Isoform
30%
B Cell
30%
Missense
30%
Precursor
30%
Pharmacogenetics
30%
Drive
30%
Von Hippel-Lindau Disease
30%
Genotyping
30%
Mitogen-Activated Protein Kinase
30%
Somatic Fusion
30%
Gene Expression
30%
Chick
30%
MSH6
30%
Gene Network
30%
Haploinsufficiency
30%
Polymerase Chain Reaction
30%
Nucleoside Analog
30%
Clonal Evolution
25%
Metabolic Pathway
20%
Small Hairpin RNA
15%
Chemosensitivity
15%
Epigenetics
15%
Scanning Electron Microscopy
15%
Drug Sensitivity
15%
Genetics
15%
Wild Type
15%
DNA Mismatch Repair
15%
Extracellular Signal-Regulated Kinases
12%
Minimum Inhibitory Concentration
12%
Trametinib
12%
IC50
11%
Tioguanine
11%
Tumor Suppressor Gene
10%
RNA Sequencing
10%
Genome Variation
10%
Receptor Tyrosine Kinase
10%
Von Hippel-Lindau Tumor Suppressor
10%
ATAC-Seq
10%
RNA Sequence
10%
Human Genome
10%
Patient Coding
10%
Gene Fusion
10%
LMNA
10%